François Radvanyi Selected Research

François Radvanyi Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 12/2004
30	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 03/2010
15	Carcinoma (Carcinomatosis) 04/2024 - 01/2003
5	Retinoblastoma (Glioblastoma, Retinal) 01/2023 - 01/2019
4	Non-Muscle Invasive Bladder Neoplasms 12/2023 - 09/2010
4	Breast Neoplasms (Breast Cancer) 03/2014 - 09/2008
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2010
2	Carcinogenesis 01/2023 - 01/2006
1	Ureteral Neoplasms (Ureteral Cancer) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Tertiary Lymphoid Structures 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Necrosis 01/2019
1	Virus Diseases (Viral Diseases) 11/2018
1	Adenocarcinoma 11/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2013
1	Carcinoma in Situ 01/2012
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2008
1	Squamous Cell Carcinoma of Head and Neck 05/2007
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2006
11	Proteins (Proteins, Gene)FDA Link 06/2023 - 05/2006
8	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 12/2004
8	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 01/2003
7	Phenobarbital (Luminal)FDA Link 11/2023 - 04/2008
4	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2011
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2022 - 12/2004
4	Messenger RNA (mRNA)IBA 10/2019 - 05/2005
4	ErbB Receptors (EGF Receptor)IBA 10/2015 - 05/2006
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2021
3	ChromatinIBA 11/2021 - 09/2006
3	ParaffinIBA 01/2020 - 04/2007
3	Small Interfering RNA (siRNA)IBA 03/2014 - 10/2009
2	LigandsIBA 06/2023 - 09/2017
2	CarcinogensIBA 01/2023 - 01/2005
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2023
2	Gemcitabine FDA Link 03/2020 - 01/2015
2	Phosphotransferases (Kinase)IBA 11/2018 - 09/2017
2	Growth Factor ReceptorsIBA 09/2017 - 03/2010
2	Formaldehyde (Formol)FDA Link 11/2016 - 04/2007
2	Protein Isoforms (Isoforms)IBA 03/2005 - 12/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	uridylyl-(3'-5')-guanosineIBA 06/2023
1	phosphatidylinositol 3-phosphateIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	CytokinesIBA 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022
1	Circulating Tumor DNAIBA 01/2021
1	InterferonsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ProteomeIBA 01/2021
1	mesoglycanIBA 12/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2020
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020
1	Methotrexate (Mexate)FDA LinkGeneric 03/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	KinesinsIBA 11/2019
1	c-Mer Tyrosine KinaseIBA 01/2019
1	Insulin (Novolin)FDA Link 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017
1	Carrier Proteins (Binding Protein)IBA 09/2017
1	PlatinumIBA 01/2015
1	SaltsIBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	DecorinIBA 12/2013
1	Histones (Histone)IBA 12/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2012
1	rab GTP-Binding ProteinsIBA 01/2012
1	Cadherins (E-Cadherin)IBA 03/2010
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2010
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2008
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 09/2008
1	Estrogen ReceptorsIBA 04/2008
1	Gefitinib (Iressa)FDA Link 05/2006
1	Tyrosine Kinase InhibitorsIBA 05/2006
1	Mitogen-Activated Protein KinasesIBA 05/2006
1	Viral DNAIBA 10/2005
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2004
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004

Therapy/Procedure

12	Therapeutics 01/2022 - 10/2009
6	Cystectomy 12/2023 - 10/2019
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
3	Immunotherapy 01/2022 - 11/2016
2	Radiotherapy 08/2022 - 12/2020
1	Neoadjuvant Therapy 03/2020
1	Adjuvant Chemotherapy 03/2020